Application of Mendelian randomization to explore metabolic pathways in colorectal cancer
This study highlights genetically predicted metabolites associated with CRC risk, suggesting that metabolite panels and lipid-based biomarkers have potential for CRC risk assessment and early detection. However, further standardization and extensive validation are necessary before its clinical application.
Authors
- Tho Thi Anh Tran (ORCID: https://orcid.org/0000-0002-4712-257X)
- Van Mai Truong (ORCID: https://orcid.org/0000-0002-1473-9485)
- Tung Hoang (ORCID: https://orcid.org/0000-0001-6653-3406)
Institutions
- Vietnam National University Ho Chi Minh City (VN)
- Hanoi Medical University (VN)
- Khanh Hoa General Hospital (VN)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1097/ms9.0000000000004020
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00